Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Matinas Biopharma Holdings
AddedFeb 20, 2024
UpdatedJun 18, 2026
Matinas Biopharma Holdings

Matinas Biopharma Holdings

Public

NJ-based Matinas BioPharma provides clinical-stage biopharmaceutical services, encapsulating various medicines.

HQ
Bedminster, NJ, US
Founded
2013
Overview
Compare
Employees
Website

Founded in Bedminster, New Jersey, Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. Its core mission is to revolutionize the delivery of small molecule drugs, oligonucleotides, vaccines, peptides, and proteins through its proprietary lipid nano-crystal (LNC) platform. The company focuses on developing innovative therapies to address significant unmet medical needs, particularly in the areas of infectious diseases and cardiometabolic conditions.

Matinas BioPharma has notable affiliations with experts like Dr. David S. Perlin, a recognized authority in antifungal treatments. The company has achieved significant milestones, including presenting new in vitro data at prominent conferences such as TIDES USA and the ASGCT Annual Meeting. These achievements underscore its impact on advancing drug delivery technologies and enhancing therapeutic efficacy.

Matinas Biopharma Holdings - Similar Companies

MatriSys Bioscience logo

MatriSys Bioscience

matrisysbio.com

Mana.bio logo

Mana.bio

mana.bio

PharmaIN logo

PharmaIN

pharmain.com

Metis Therapeutics logo

Metis Therapeutics

metistx.com

Lipidio Pharmaceuticals logo

Lipidio Pharmaceuticals

lipidiopharma.com

Mantra Bio logo

Mantra Bio

mantrabio.com

Mati Therapeutics logo

Mati Therapeutics

Biofrontera logo

Biofrontera

biofrontera.com

Ziran Biopharmaceutical logo

Ziran Biopharmaceutical

Actinobac Biomed logo

Actinobac Biomed

Surf Bio logo

Surf Bio

surf.bio

InSitu Biologics logo

InSitu Biologics

Lisata Therapeutics logo

Lisata Therapeutics

lisata.com

LipimetiX logo

LipimetiX

Optimeos Life Sciences logo

Optimeos Life Sciences

optimeos.com

Matinas Biopharma Holdings - Quick Facts

Who are Matinas Biopharma Holdings' competitors?

Companies similar to Matinas Biopharma Holdings include MatriSys Bioscience, Mana.bio, PharmaIN and Metis Therapeutics.

When was Matinas Biopharma Holdings founded?

Matinas Biopharma Holdings was founded in 2013.

Where is Matinas Biopharma Holdings' headquarters located?

Matinas Biopharma Holdings' headquarters is located in Bedminster, NJ, US.

How many employees does Matinas Biopharma Holdings have?

Matinas Biopharma Holdings has 34 employees as of Feb 6, 2024.

Matinas Biopharma Holdings - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Biotech
  • Healthtech
Unique IDs
  • ein: 463011414
  • secCik: 0001582554
  • ticker: MTNB
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research